Skip to main content
Erschienen in: Cancer Causes & Control 5/2012

01.05.2012 | Original paper

Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years

verfasst von: Shu-Fen Liao, Wen-Chung Lee, Hui-Chi Chen, Li-Chung Chuang, Mei-Hung Pan, Chien-Jen Chen

Erschienen in: Cancer Causes & Control | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Human papillomavirus (HPV) has been recognized as a major factor for cervical cancer causation. Other factors, relating to reproduction, are also important. This study aims to disentangle the roles of baseline HPV infection, high vaginal parity (defined as having ≥4 vaginal deliveries), and the interaction between the two in predicting cervical cancer risk.

Methods

The authors apply a newly developed causal-pie modeling technique to analyze a cohort of more than 10,000 women conducted in Taiwan with more than 10 years of follow-up. The rate ratios adjusted by age and menopausal status were further modeled by an additive Poisson regression with non-negative parameters. The index of causal-pie weight (CPW) was calculated to indicate the proportion of cervical cancer cases attributable to a particular class of causal pies.

Results

It was found that the CPWs are 36.3 % for baseline HPV infection, 35.6 % for baseline HPV infection and high vaginal parity, and 28.1 % for other factors.

Conclusions

A causal-pie modeling based on a women cohort in Taiwan successfully disentangles the roles of virus factors and reproductive factors at study entry, independently or interactively, on subsequent cervical cancer risk.
Literatur
1.
Zurück zum Zitat Bosch FX, de Sanjose S (2003) Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 31:3–13PubMedCrossRef Bosch FX, de Sanjose S (2003) Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 31:3–13PubMedCrossRef
2.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN (2008), Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN (2008), Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://​globocan.​iarc.​fr
5.
Zurück zum Zitat Munoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1–5PubMedCrossRef Munoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1–5PubMedCrossRef
6.
Zurück zum Zitat Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedCrossRef Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedCrossRef
7.
Zurück zum Zitat Bosch FX, de Sanjose S (2007) The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 23:213–227PubMed Bosch FX, de Sanjose S (2007) The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 23:213–227PubMed
8.
Zurück zum Zitat Steben M, Duarte-Franco E (2007) Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 107:S2–S5PubMedCrossRef Steben M, Duarte-Franco E (2007) Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 107:S2–S5PubMedCrossRef
9.
Zurück zum Zitat Koutsky LA, Holmes KK, Critchlow CW et al (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327:1272–1278PubMedCrossRef Koutsky LA, Holmes KK, Critchlow CW et al (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327:1272–1278PubMedCrossRef
10.
Zurück zum Zitat Sherman ME, Lorincz AT, Scott DR et al (2003) Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95:46–52PubMedCrossRef Sherman ME, Lorincz AT, Scott DR et al (2003) Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95:46–52PubMedCrossRef
11.
Zurück zum Zitat Woodman CB, Collins S, Winter H et al (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357:1831–1836PubMedCrossRef Woodman CB, Collins S, Winter H et al (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357:1831–1836PubMedCrossRef
12.
Zurück zum Zitat Hildesheim A, Herrero R, Castle PE et al (2001) HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219–1226PubMedCrossRef Hildesheim A, Herrero R, Castle PE et al (2001) HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219–1226PubMedCrossRef
13.
Zurück zum Zitat Castellsague X, Munoz N (2003) Chapter 3: cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20–28PubMedCrossRef Castellsague X, Munoz N (2003) Chapter 3: cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20–28PubMedCrossRef
14.
Zurück zum Zitat Castellsague X, Bosch FX, Munoz N (2002) Environmental co-factors in HPV carcinogenesis. Virus Res 89:191–199PubMedCrossRef Castellsague X, Bosch FX, Munoz N (2002) Environmental co-factors in HPV carcinogenesis. Virus Res 89:191–199PubMedCrossRef
15.
Zurück zum Zitat Vaccarella S, Herrero R, Dai M et al (2006) Reproductive factors, oral contraceptives use, and human papillomavirus infection: pooled analysis of the IARC prevalence surveys. Cancer Epidemiol Biomarkers Prev 15:2148–2153PubMedCrossRef Vaccarella S, Herrero R, Dai M et al (2006) Reproductive factors, oral contraceptives use, and human papillomavirus infection: pooled analysis of the IARC prevalence surveys. Cancer Epidemiol Biomarkers Prev 15:2148–2153PubMedCrossRef
16.
Zurück zum Zitat Munoz N, Franceschi S, Bosetti C et al (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359:1093–1101PubMedCrossRef Munoz N, Franceschi S, Bosetti C et al (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359:1093–1101PubMedCrossRef
17.
Zurück zum Zitat Louie KS, de Sanjose S, Diaz M et al (2009) Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer 100:1191–1197PubMedCrossRef Louie KS, de Sanjose S, Diaz M et al (2009) Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer 100:1191–1197PubMedCrossRef
18.
Zurück zum Zitat Liao SF, Lee WC (2010) Weighing the causal pies in case-control studies. Ann Epidemiol 20:568–573PubMedCrossRef Liao SF, Lee WC (2010) Weighing the causal pies in case-control studies. Ann Epidemiol 20:568–573PubMedCrossRef
19.
Zurück zum Zitat International Agency for Research on Cancer (IARC) (2009) A review of human carcinogens-Part B: biological agents. Lancet 10:321–322 International Agency for Research on Cancer (IARC) (2009) A review of human carcinogens-Part B: biological agents. Lancet 10:321–322
20.
Zurück zum Zitat Lin CY, Chao A, Yang YC et al (2008) Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 42:361–367PubMedCrossRef Lin CY, Chao A, Yang YC et al (2008) Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 42:361–367PubMedCrossRef
21.
22.
Zurück zum Zitat Rothman KJ, Greenland S, Lash TL (eds) (2008) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, PA Rothman KJ, Greenland S, Lash TL (eds) (2008) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, PA
23.
Zurück zum Zitat Skrondal A (2003) Interaction as departure from additivity in case-control studies: a cautionary note. Am J Epidemiol 158:251–258PubMedCrossRef Skrondal A (2003) Interaction as departure from additivity in case-control studies: a cautionary note. Am J Epidemiol 158:251–258PubMedCrossRef
24.
Zurück zum Zitat Munoz N, Bosch FX, de Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527PubMedCrossRef Munoz N, Bosch FX, de Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527PubMedCrossRef
25.
Zurück zum Zitat Schiffman M, Castle PE, Jeronimo J, Rodriquez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370:890–907PubMedCrossRef Schiffman M, Castle PE, Jeronimo J, Rodriquez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370:890–907PubMedCrossRef
Metadaten
Titel
Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years
verfasst von
Shu-Fen Liao
Wen-Chung Lee
Hui-Chi Chen
Li-Chung Chuang
Mei-Hung Pan
Chien-Jen Chen
Publikationsdatum
01.05.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 5/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-9939-4

Weitere Artikel der Ausgabe 5/2012

Cancer Causes & Control 5/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.